These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 39187481)

  • 1. Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade.
    Holzgruber J; Martins C; Kulcsar Z; Duplaine A; Rasbach E; Migayron L; Singh P; Statham E; Landsberg J; Boniface K; Seneschal J; Hoetzenecker W; Berdan EL; Ho Sui S; Ramsey MR; Barthel SR; Schatton T
    Nat Commun; 2024 Aug; 15(1):7165. PubMed ID: 39187481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I Interferon Activates PD-1 Expression through Activation of the STAT1-IRF2 Pathway in Myeloid Cells.
    Liang L; Yang Y; Deng K; Wu Y; Li Y; Bai L; Wang Y; Lu C
    Cells; 2024 Jul; 13(13):. PubMed ID: 38995014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alpha.
    Tsuno T; Mejido J; Zhao T; Schmeisser H; Morrow A; Zoon KC
    J Immunother; 2009 Oct; 32(8):803-16. PubMed ID: 19752753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor Cells.
    Xiao W; Klement JD; Lu C; Ibrahim ML; Liu K
    J Immunol; 2018 Jul; 201(1):264-277. PubMed ID: 29752314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.
    Zaritsky LA; Bedsaul JR; Zoon KC
    J Virol; 2015 Nov; 89(22):11534-48. PubMed ID: 26355085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha.
    Zhao LJ; He SF; Liu Y; Zhao P; Bian ZQ; Qi ZT
    Cell Physiol Biochem; 2016; 40(1-2):77-90. PubMed ID: 27855377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway.
    Chen DY; Khan N; Close BJ; Goel RK; Blum B; Tavares AH; Kenney D; Conway HL; Ewoldt JK; Chitalia VC; Crossland NA; Chen CS; Kotton DN; Baker SC; Fuchs SY; Connor JH; Douam F; Emili A; Saeed M
    J Virol; 2021 Sep; 95(19):e0086221. PubMed ID: 34260266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAM and Hrs interact sequentially with IFN-α Receptor to control spatiotemporal JAK-STAT endosomal activation.
    Zanin N; Viaris de Lesegno C; Podkalicka J; Meyer T; Gonzalez Troncoso P; Bun P; Danglot L; Chmiest D; Urbé S; Piehler J; Blouin CM; Lamaze C
    Nat Cell Biol; 2023 Mar; 25(3):425-438. PubMed ID: 36797476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal expression levels of IFNAR and Jak-STAT components are determinants of cell-type-specific differences in cardiac antiviral responses.
    Zurney J; Howard KE; Sherry B
    J Virol; 2007 Dec; 81(24):13668-80. PubMed ID: 17942530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmitoylation of interferon-alpha (IFN-alpha) receptor subunit IFNAR1 is required for the activation of Stat1 and Stat2 by IFN-alpha.
    Claudinon J; Gonnord P; Beslard E; Marchetti M; Mitchell K; Boularan C; Johannes L; Eid P; Lamaze C
    J Biol Chem; 2009 Sep; 284(36):24328-40. PubMed ID: 19561067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I interferon-regulated gene expression and signaling in murine mixed glial cells lacking signal transducers and activators of transcription 1 or 2 or interferon regulatory factor 9.
    Li W; Hofer MJ; Songkhunawej P; Jung SR; Hancock D; Denyer G; Campbell IL
    J Biol Chem; 2017 Apr; 292(14):5845-5859. PubMed ID: 28213522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal transduction.
    Bisson SA; Page AL; Ganem D
    J Virol; 2009 May; 83(10):5056-66. PubMed ID: 19279093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes Simplex Virus 1 UL36USP Antagonizes Type I Interferon-Mediated Antiviral Innate Immunity.
    Yuan H; You J; You H; Zheng C
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
    Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta interferon-mediated activation of signal transducer and activator of transcription protein 1 interferes with Rickettsia conorii replication in human endothelial cells.
    Colonne PM; Eremeeva ME; Sahni SK
    Infect Immun; 2011 Sep; 79(9):3733-43. PubMed ID: 21690236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells.
    Hirano K; Ichikawa T; Nakao K; Matsumoto A; Miyaaki H; Shibata H; Eguchi S; Takatsuki M; Ikeda M; Yamasaki H; Kato N; Kanematsu T; Ishii N; Eguchi K
    Liver Transpl; 2008 Mar; 14(3):292-8. PubMed ID: 18306331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emodin potentiates the antiproliferative effect of interferon α/β by activation of JAK/STAT pathway signaling through inhibition of the 26S proteasome.
    He Y; Huang J; Wang P; Shen X; Li S; Yang L; Liu W; Suksamrarn A; Zhang G; Wang F
    Oncotarget; 2016 Jan; 7(4):4664-79. PubMed ID: 26683360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-based Knockout Strategy Elucidates Components Essential for Type 1 Interferon Signaling in Human HeLa Cells.
    Urin V; Shemesh M; Schreiber G
    J Mol Biol; 2019 Aug; 431(17):3324-3338. PubMed ID: 31207241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation.
    Jiang L; Park MJ; Cho CJ; Lee K; Jung MK; Pack CG; Myung SJ; Chang S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.